Marrow stromal cells for cellular cardiomyoplasty: Feasibility and potential clinical advantages
Open Access
- 1 November 2000
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 120 (5) , 999-1006
- https://doi.org/10.1067/mtc.2000.110250
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Multilineage Potential of Adult Human Mesenchymal Stem CellsScience, 1999
- Cardiomyocyte Transplantation Improves Heart FunctionThe Annals of Thoracic Surgery, 1996
- Genetically selected cardiomyocytes from differentiating embronic stem cells form stable intracardiac grafts.Journal of Clinical Investigation, 1996
- Arterial delivery of genetically labelled skeletal myoblasts to the murine heart: Long-term survival and phenotypic modification of implanted myoblastsCell Transplantation, 1996
- Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5‐azacytidineMuscle & Nerve, 1995
- Differentiation and long-term survival of C2C12 myoblast grafts in heart.Journal of Clinical Investigation, 1993
- Myocyte loss and left ventricular failure characterise the long term effects of coronary artery narrowing or renal hypertension in ratsCardiovascular Research, 1993
- Prevalence and mortality rate of congestive heart failure in the United StatesJournal of the American College of Cardiology, 1992
- Mesenchymal stem cellsJournal of Orthopaedic Research, 1991
- Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptidesNature, 1988